updates on care and research for children with ...07d0901f-86b6-4cd... · updates on care and...
TRANSCRIPT
8/18/2014
1
Updates on care and research for children with developmental
disabilities and autism
Carlos A. Bacino, M.D.
Dept. of Molecular and Human Genetics
Baylor College of Medicine y
Texas Children’s Hospital
Houston, Texas, USA
Intellectual Disability
• A disability characterized by significant limitations both in intellectual functioning (IQ<70) and in adaptive behavior (everyday social and practical skills).
• Onset before the age of 18
• By definition affects 2% of the general population.
8/18/2014
2
Normal distribution
• The median of any “IQ” test is usually set at 100, and the standard deviation is set at 15
• For a normal distribution, ~95% of the population will fall between two standard deviations of the mean (70-130)
Intellectual Disability
• Characterized by below-average intelligence or mental ability
• Lack of skills necessary for day-to-day living • People with intellectual disabilities can and do learn new
skills, but they learn them more slowly Limitations in: • Intellectual functioning. Also known as IQ, this refers to a
person’s ability to learn, reason, make decisions, and solve problems.
• Adaptive behaviors. These are skills necessary for day-to-day life, such as being able to communicate effectively, interact with others, and take care of oneself.
8/18/2014
3
Causes of Developmental Disabilities
Chromosome problems: Down syndrome, VCFS, Williams syndrome, etc.
Cerebral palsy
Rare genetic problems: Fragile X syndrome, Angelman syndrome, Prader-Willi syndrome, etc.
Prenatal exposures, infections
Metabolic diseases
Unknown causes in 50% of cases
Identifiable genetic causes of ID
25% chromosomal aberrations 25% monogenic causes
~ 45% unknown
<5% teratogenic exposures
<5%perinatal complications
8/18/2014
4
Most common genetic causes of ID
• #1: Trisomy 21 (Down Syndrome), 1:650
• #2: Fragile X syndrome, 1:4000 (males), 1:8000 (females)
• #3: Rett syndrome, 1:8500 (females)
Clinical Description of Autism Spectrum
Disorders (ASDs)
First described by
Leo Kanner (1943); Hans Asperger (1944
Characterized by:
– Impairments in social interaction and communication
–Restricted, stereotyped patterns of behavior and
interests
–Moderate to severe language delay
–Onset before 3 years of age
Comorbid conditions:
Intellectual disabilities (25-70%); epilepsy (5–38%),
anxiety (11-85%)
8/18/2014
5
Autism spectrum disorders (ASD)
• ASD is estimated to affect 8.6–9.3 per 1,000 children (up to
8 years of age)
• CDC’s calculations: Of 4 million children born in the United
States each year, approximately 36,500 will eventually be
diagnosed with ASD. We can estimate that about 730,000
individuals between the ages of 0 to 21 have an ASD.
(MMWR, 2009 & http://www.cdc.gov)
No.
of A
SD
/1,0
00 c
hild
ren
ASD has a strong genetic basis
• Male predominance (M:F = 4-5:1)
• Concordance rate up to 96% in monozygotic twins
(9% in dizygotic twins)
• 10-15% of autism cases have an identifiable genetic condition or chromosomal problem
• Recurrence: 4% for girls, 7% boys (one affected), 25-50% if a second child is affected.
8/18/2014
6
Signs for Autism
• No words by age 2
• Poor eye contact
• No response to name being called
• Not playing with toys in the correct way
• Repetitive motor behaviors (hand flapping, spinning)
• Loss of any skills before age 3
Autism
Childhood Disintegrative Disorder
Asperger's Syndrome PDD-NOS
Autism Spectrum Disorder
8/18/2014
7
AUTISM VERY DIFFERENT GROUPS
• Syndromic, dysmorphic
• Higher fraction MR
• Genetic clinic series
• 25-30% findable mutations
• Male:female = ~2:1
• Essential, idiopathic, nondysmorphic
• Higher functioning
• +/- 10 % findable mutations
• Male:female = ~8:1
Syndromic Autism
Rett syndrome MECP2
16p11.2 del KCTD13
Angelman syndrome UBE3A
FraX syndrome FMR1
PTEN assoc. disorders PTEN
Tuberous sclerosis TSC1, TSC2
8/18/2014
8
Autism and Genetic Disorders
• Autism has been described in association with a number of genetic conditions including: – Rett syndrome, tuberous sclerosis, Angelman
Syndrome, Prader-Willi Syndrome, Down Syndrome, Fragile X syndrome, and 22q deletion syndromes.
How can a genetics doctor help you and your child? Questions:
• What is the diagnosis?
• What is the cause?
• What is going to happen in the future?
• What is the treatment?
8/18/2014
9
Normal Male Chromosomes
8/18/2014
10
Normal Female Chromosomes
47,XY,+21 Down Syndrome
8/18/2014
11
New testing
Called chromosome microarray
Can see much smaller chromosome or gene changes
Example
46,XY,der(14;21)(q10;q10),+21 Chromosome 21-specific plot
8/18/2014
12
Diagnosis and Counseling
If a diagnosis is made:
give information about the condition
possible medical complications
design a treatment plan
Offer counseling about chance for condition to occur in future children
Diagnosis and Counseling
Discuss reproductive options
Provide information about care before becoming pregnant: – take folic acid
– keep good control of diabetes
– stop drinking alcohol and smoking
Help with family support and coping
8/18/2014
13
Clinical Evaluations for Intellectual Disability & Autism
ADOS-G and ADI-R
Clinical evaluation for known syndromes
Special attention to facial features
Woods lamp evaluation (UV light)
Brain imaging studies: MRI and MR Spectroscopy
Laboratory Testing for ID & Autism
Chromosome microarray testing (array CGH) Urine organic acids Urine MPS Lactic acid Plasma aminoacids Acyl-carnitine profile Fragile-X testing in males DNA testing for PTEN mutations if macrocephaly
present (3-4 SD above the mean) MECP2 sequencing in females
PMID: 18414214 - Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genetics in Medicine. 2008 Apr 10(4):301-5.
8/18/2014
14
Fragile X syndrome
• Intellectual disability mild to profound; autistic-like w/hand-flapping; repetitive, explosive, stuttering, stammering speech; seizures
• Develop large testes after puberty or by adulthood
• Mild connective tissue dysplasia - joint laxity
Fragile X syndrome
Other: large head size, large jaw, long face, large ears, pale blue irises of eyes, mitral prolapse in heart (valve in the heart)
Trinucleotide expansion disease
(expansion of genetic instruction) that causes gene non functional
- Diagnosis = Fragile X DNA testing
8/18/2014
15
Autism present in 15-30 % of patients with FraX
Classic Rett Syndrome
Normal development until 6-18 months, when child begins to regress:
-Head growth slows -Language skills disappear -Stereotypic movements
replace purposeful hand use -Autistic features appear, lose
ability to walk, seizures, breathing pattern not regular
8/18/2014
16
MeCP2 Region Duplications
• Changes in the MECP2 gene cause classic Rett Syndrome and can cause intellectual disabilities, autistic spectrum disorders
• Infantile hypotonia (low muscle tone)
• Significant speech/language delays
• Some also have seizures, autistic features, and progressive loss of walking ability
Deletions of 22q13.3
• Phelan-McDermid syndrome
• More than 50% of patients show autism or autistic-like behavior, and therefore it can be classified as a syndromic form of autism spectrum disorders
• Involving SHANK3
8/18/2014
17
Hypotonic facies, long smooth philtrum, nail dysplasia
SHANK3 and Autism
SHANK3 regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome
8/18/2014
18
GAIN on 15q11.2q13.1 and autism
• Nonspecific facial dysmorphic features
• Variable degree of language delay and developmental delay
• Autism-spectrum behavioral abnormalities
Patients with
7q11.23 dup
involving the
Williams syndrome
critical region
8/18/2014
19
An example – 16p11.2 deletions and duplications
One of the most common “copy number variants” associated to autism spectrum disorders
A deletion or duplication in 16p11.2 is identified in 1-2% of all patients with ASD
Can be “syndromic ASD”, but often “non-syndromic”
One mutation – multiple disorders
Autism ADHD
Bipolar
alcoholism
depression, suicide
alcoholism
ADHD
8/18/2014
20
Tuberous Sclerosis Complex
• Autosomal Dominant
• 1/6000 individuals
• 30% inherited
• 70% sporadic
• Marked Clinical Variability
TSC1 Hamartin
TSC2 Tuberin
Van Slegtenhorst M De Hoogt R, et al. Science 1997; 277:805-8
European Chromosome 16 Tuberous sclerosis Consortium. Cell 1993;75:1305-15
Tuberous sclerosis: Skin
• Achromic lesions
8/18/2014
21
Whole Exome Sequencing Testing
• There are ~ 22.000 genes in the genome
• There are a total of 180.000 exons in the human genome
• This allows detection of hundreds of mutations all at once
8/18/2014
22
What is an exome?
• Exons are the short, functionally important sequences of DNA which represent the regions in genes that are translated into protein
• The exome is 1.5-2 % of the whole genome, but makes up the part of the genome we best understand
8/18/2014 W H O L E E X O M E S E Q U E N C I N G 43
What is Whole Exome Sequencing (WES)?
• Test that “captures” or selects the coding regions or exons throughout the whole genome to then be sequenced nucleotide by nucleotide to a depth of coverage necessary to build a consensus sequence with high accuracy.
• This consensus sequence is then compared to standards and references of what is normal in the population
• Once identified through WES variations in an individual's DNA sequence can be related back to the individual's medical concerns in an effort to diagnose the cause of the medical disorder.
8/18/2014 W H O L E E X O M E S E Q U E N C I N G 44
8/18/2014
23
Goal of Clinical WES
• Obtaining a diagnostic result
• Improve preventive care through identification of medically actionable result
• Probable cost-effectiveness
8/18/2014 W H O L E E X O M E S E Q U E N C I N G 45
Exome Sequencing Studies in Autism
Potential Genes in Autism
• CHD8
• NTNG1
• KATNAL2
• GRIN2B
• LAMC3
• SCN1A
• SCN2A
Known Genes in Autism
• PTEN
• SHANK3
• MECP2
• NRXN1
• CNTNAP2
8/18/2014
24
Conclusions • Now able to find many more causes of developmental
disorders and autism with new chromosome microarray and metabolic studies
• Chromosome abnormalities are very common in developmental delay and autism (up to 1 in 100 liveborn babies)
• Technology continues to advance, what is next? Whole Exome Sequencing and Whole Genome Sequencing
• Discovery of genes, pathways involved in diseases is leading the way to new treatments
Back to the patients Why is it even worth knowing?
“Get an answer”
Chance of recurrence for future pregnancies
Find support groups – individuals with same genetic variant
Anticipatory guidance
Change medical follow-up and screening
Therapies and research
8/18/2014
25
Web Resources
• Genetic & Rare Diseases Information Center http://rarediseases.info.nih.gov/GARD
• Genetic Alliance: www.geneticalliance.org
• Texas Department of State Health Services: http://www.dshs.state.tx.us/genetics/pedi-genetics.shtm
• Chromosome Disorder Outreach: www.chromodisorder.org
• Unique http://www.rarechromo.org
Thank you
• This webinar has been possible thanks to Title V Funding from the Texas Department of State Health Services.
• Thank you to Rachel Moyer-Trimyer with DARS for facilitating this webinar.